Patients should be advised to report any febrile illness to their physicians (see WARNINGS: Neutropenia).

Patients and caregivers should be advised that RILUTEK (riluzole) should be taken on a regular basis and at the same time of the day (e.g., in the morning and evening) each day. If a dose is missed, take the next tablet as originally planned (see DOSAGE AND ADMINISTRATION).

Patients should be warned about the potential for dizziness, vertigo, or somnolence and advised not to drive or operate machinery until they have gained sufficient experience on RILUTEK (riluzole) to gauge whether or not it affects their mental and/or motor performance adversely.

Whether alcohol increases the risk of serious hepatotoxicity with RILUTEK (riluzole) is unknown; therefore, patients being treated with RILUTEK (riluzole) should be discouraged from drinking excessive amounts of alcohol.

Patients should also be made aware that RILUTEK (riluzole) should be stored at temperatures between 20°-25°C (68°-77°F) and protected from bright light.

RILUTEK (riluzole) must be kept out of the reach of children.

Last reviewed on RxList: 8/5/2009
This monograph has been modified to include the generic and brand name in many instances.